Imaginab Is A Biotech Company Based In Inglewoodcaliforniafounded In 2007The Company Specializes In Developing Targeted Molecular Imaging Agentsparticularly For Cancer And Autoimmune Diseasesimaginab Is Recognized For Its Innovative Approach To Immuno Oncology Imagingwhich Provides Valuable Insights Into Patient Immunity Status The Company S Primary Offerings Include Advanced Imaging Agents And Radiopharmaceutical Therapy Productsits Flagship Productthe Cd8 Immunopetis Currently In Phase 2 Clinical Trials And Is Licensed By Various Pharmaceutical And Biotech Companies For Use In Immunotherapy Clinical Trialsimaginab Is Also Developing A Prostate Cancer Imaging Agentwhich Is Being Evaluated As A Surgical Resection Tool Imaginab Has A Strong Leadership Teamincluding Founder Dranna Wuwho Guides The Company S Scientific Directionthe Company Has Raised A Total Of $61 86 Million In Funding And Is Focused On Advancing Its Imaging Products Following The Recent Sale Of Its Biologics Technology Platform To Telix Pharmaceuticals
